179 related articles for article (PubMed ID: 7797120)
1. Translocation of gliadin into HLA-DR antigen containing lysosomes in coeliac disease enterocytes.
Zimmer KP; Poremba C; Weber P; Ciclitira PJ; Harms E
Gut; 1995 May; 36(5):703-9. PubMed ID: 7797120
[TBL] [Abstract][Full Text] [Related]
2. Endocytotic segregation of gliadin peptide 31-49 in enterocytes.
Zimmer KP; Fischer I; Mothes T; Weissen-Plenz G; Schmitz M; Wieser H; Büning J; Lerch MM; Ciclitira PC; Weber P; Naim HY
Gut; 2010 Mar; 59(3):300-10. PubMed ID: 19654123
[TBL] [Abstract][Full Text] [Related]
3. Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.
Fais S; Maiuri L; Pallone F; De Vincenzi M; De Ritis G; Troncone R; Auricchio S
Gut; 1992 Apr; 33(4):472-5. PubMed ID: 1582589
[TBL] [Abstract][Full Text] [Related]
4. Targeting of gliadin peptides, CD8, alpha/beta-TCR, and gamma/delta-TCR to Golgi complexes and vacuoles within celiac disease enterocytes.
Zimmer KP; Naim H; Weber P; Ellis HJ; Ciclitira PJ
FASEB J; 1998 Oct; 12(13):1349-57. PubMed ID: 9761778
[TBL] [Abstract][Full Text] [Related]
5. Correction of gliadin transport within enterocytes through celiac disease serum.
Lübbing N; Barone MV; Rudloff S; Troncone R; Auricchio S; Zimmer KP
Pediatr Res; 2011 Oct; 70(4):357-62. PubMed ID: 21705964
[TBL] [Abstract][Full Text] [Related]
6. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides.
Lebreton C; Ménard S; Abed J; Moura IC; Coppo R; Dugave C; Monteiro RC; Fricot A; Traore MG; Griffin M; Cellier C; Malamut G; Cerf-Bensussan N; Heyman M
Gastroenterology; 2012 Sep; 143(3):698-707.e4. PubMed ID: 22750506
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR expression, natural killer cells and IgE containing cells in the jejunal mucosa of coeliac children.
Arato A; Savilahti E; Tainio VM; Verkasalo M; Klemola T
Gut; 1987 Aug; 28(8):988-94. PubMed ID: 3311907
[TBL] [Abstract][Full Text] [Related]
8. The effect of gluten on HLA-DR in the small intestinal epithelium of patients with coeliac disease.
Ciclitira PJ; Nelufer JM; Ellis HJ; Evans DJ
Clin Exp Immunol; 1986 Jan; 63(1):101-4. PubMed ID: 3514010
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease.
Marley NJ; Macartney JC; Ciclitira PJ
Clin Exp Immunol; 1987 Nov; 70(2):386-93. PubMed ID: 3322617
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study.
Ciacci C; Maiuri L; Russo I; Tortora R; Bucci C; Cappello C; Santonicola A; Luciani A; Passananti V; Iovino P
Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1170-6. PubMed ID: 19473192
[TBL] [Abstract][Full Text] [Related]
11. In vivo gluten ingestion in coeliac disease.
Ciclitira PJ; Ellis HJ
Dig Dis; 1998; 16(6):337-40. PubMed ID: 10207218
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa.
Maiuri L; Troncone R; Mayer M; Coletta S; Picarelli A; De Vincenzi M; Pavone V; Auricchio S
Scand J Gastroenterol; 1996 Mar; 31(3):247-53. PubMed ID: 8833354
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue.
Schumann M; Richter JF; Wedell I; Moos V; Zimmermann-Kordmann M; Schneider T; Daum S; Zeitz M; Fromm M; Schulzke JD
Gut; 2008 Jun; 57(6):747-54. PubMed ID: 18305066
[TBL] [Abstract][Full Text] [Related]
14. Increase in T-cell subsets of oral mucosa: a late immune response in patients with treated coeliac disease?
Lähteenoja H; Toivanen A; Viander M; Räihä I; Rantala I; Syrjänen S; Mäki M
Scand J Immunol; 2000 Dec; 52(6):602-8. PubMed ID: 11119267
[TBL] [Abstract][Full Text] [Related]
15. Expression of major histocompatibility complex class II subregion products by jejunal epithelium in patients with coeliac disease.
Scott H; Sollid LM; Fausa O; Brandtzaeg P; Thorsby E
Scand J Immunol; 1987 Nov; 26(5):563-71. PubMed ID: 3500504
[TBL] [Abstract][Full Text] [Related]
16. Dissociation between systemic and mucosal humoral immune responses in coeliac disease.
O'Mahony S; Arranz E; Barton JR; Ferguson A
Gut; 1991 Jan; 32(1):29-35. PubMed ID: 1991635
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization of class I (A,B,C) and class II (DR and DQ) MHC antigens in jejunal epithelium of children with coeliac disease.
Sarles J; Gorvel JP; Olive D; Maroux S; Mawas C; Giraud F
J Pediatr Gastroenterol Nutr; 1987; 6(1):51-6. PubMed ID: 3540260
[TBL] [Abstract][Full Text] [Related]
18. Increased HLA-DR expression by enterocytes in children with celiac disease.
Arnaud-Battandier F; Cerf-Bensussan N; Amsellem R; Schmitz J
Gastroenterology; 1986 Nov; 91(5):1206-12. PubMed ID: 3758613
[TBL] [Abstract][Full Text] [Related]
19. T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC).
O'Keeffe J; Mills K; Jackson J; Feighery C
Clin Exp Immunol; 1999 Aug; 117(2):269-76. PubMed ID: 10444257
[TBL] [Abstract][Full Text] [Related]
20. Gliadin uptake in human enterocytes. Differences between coeliac patients in remission and control individuals.
Friis S; Dabelsteen E; Sjöström H; Norén O; Jarnum S
Gut; 1992 Nov; 33(11):1487-92. PubMed ID: 1452073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
